TOP STORIES

• BUSINESS Drug Makers’ Specialty Care Pipelines Hit Snags in Late-Stage Development
  January 21, 2013

• ORGANIZATION JPMA Bolstering ICH Activities to Propose New Topics from Industry
  January 18, 2013

• BUSINESS Celgene K.K. Focused on MR Training Aiming for No. 1 Ranking Among Hematologists in 2013
  January 18, 2013

• BUSINESS OrphanPacific’s Orphan Drug Biz Faces Rough Going with Rising Costs
  January 17, 2013

• BUSINESS Domestic Drug Makers Working to Escape Dependence on Long-Listed Drugs through New Product Development
  January 17, 2013

• BUSINESS GMP Violations at Drug Substance Makers Prompt Series of New Voluntary Recalls of Generics; Stable Supplies Disrupted
  January 16, 2013

• ORGANIZATION JMA Vice Pres. Nakagawa Urges Pharmacies to Rigidly Check Medical Exam History of Epadel OTC Buyers
  January 15, 2013

• REGULATORY Focus May Be on Whether New Price Cutting Rule for Long-Listed Drugs Should Apply Only to Those Granted Premium
  January 15, 2013

• REGULATORY PMDA Probes How Insurance Pharmacies Utilize Drug Safety Information
  January 11, 2013

• BUSINESS Takeda to Pitch Lotriga for Patients with Residual Event Risks, Cultivate New Market
  January 10, 2013

• BUSINESS AbbVie to Focus on Specialty Care, “Not Interested” in Established Markets: CEO Winer
  January 9, 2013

• ORGANIZATION Efforts to Promote Generic Substitution Preferable to Cutting Prices of Long-Listed Drugs: Mr Sawai of JGA
  January 8, 2013

• BUSINESS “Appropriate Expressions” of Disease Awareness Ads Being Tested
  January 7, 2013

• ORGANIZATION Member Companies to Begin Enforcing New COP in FY2013: JPMA President Teshirogi
  January 7, 2013

• ORGANIZATION NHO to Review Calculation Method for Clinical Trial Costs
  December 28, 2012

• REGULATORY 2nd Abe Cabinet Inaugurated; Industry Awaits Decision on Perpetuation of Premium for New Drug Development
  December 27, 2012

• REGULATORY LDP to Finalize Tax Reform Outline for FY2013 by Late January
  December 26, 2012

• ORGANIZATION JMA to Discuss JPMA’s Transparency Guidelines with JPMA, Related Medical Organizations
  December 25, 2012

• REGULATORY MHLW to Establish a Venue for Discussions to Review Policies for OTC Switching of Lifestyle Disease Treatments
  December 21, 2012

• REGULATORY Osaka’s Healthcare Plan Highlights Differences in Definition of “Frequent Deliveries”
  December 21, 2012

ページ

• « 先頭
• ‹ Prev
• …
• 222
• 223
• 224
• 225
• 226
• 227
• 228
• 229
• 230
• …
• Next ›
• 最終 »